eluded researchers sil1ceits first description in 1832.1
Many etiologic faclors have been proposed, inc1uding the Epstein-Barr virus (EBV).2.4 Indeed, patients with a history ofEBV-associated il1fectious mononuc\eosis have been shown to have an increased risk of HD over control populations) and patients with HD have been shown to have abnormally high \cvels ofantibodies against EBV antigens.6 EBV genomic DNA was first reportcd in HD in 1987.7 Subsequent in situ hybridization studies have localized lhe virus lO Reed-Sternberg cells and variants (Hodgkin cells), the presumed neoplastic componenl 01'HD. 8.9More recent studies have found approximalely 40% to 50% 01' cases of classical HD occurring in immunocompetent individuals to be EBV-associated.IO.14 The association betwcen EBV and African Burkitt's Iymphoma, a B-cen neoplasm, has been well-described.l) Approximately 98% 01' the African Burkitt's tumors carry the EBV genome and the EBV-determined nuclear antigen. Additionally, serum antibody liters against viral capsid antigens are correlated with the risk of developing the tumor. In contrast, the EBV genome is found in only 15% to 20% of cases of sporadic (non-African) Burkitt's lymphoma. 16 To determine whether the association of EBV with HD also showed geographical variation, we used the techniqucs of in situ hybridization and immunohistochemistry to investigate cases of HD occurring in Peru. Our studics found that 30 of 32 cases (94%) of classical HD occurring in Peruvian patients contain EBV RNA within the Reed-Sternberg cells and variants, and in a majority ofthese cases also expressed EBV latent mcmbrallc protcin (LMPI). This is a mllch higher percentagc ofEBV-positívity than that found in studies from the United States and Europe, strongly suggesting that regions ofendemic EBV-associated HD existo similar to thc situation in Burkitt's Iymphoma.
MA TERIALS AND METHODS
Cases. Thirty-two formalin-fixe<! paraffin-cmbcddcd cases 01'HD were analyzed. The cases were derivcd from the files 01'the Hospital Belen and the Centro de Cito.Patologia 01' Trujillo. Pcru. Frozen tissue was not available for study in any case. The morphologie criteria for the diagnosis and classitication 01'HD were those previollsly cstablished.I1.18 EBV scrologic data was not available for any 01' thc patienL5.
11/s'illl hybridizalion studie.\'. The EBV RNA in situ hybridization studies were performed using a 30-base oligonueleotide complementary to a portion 01'the EBER I gene. a region 01' the EBV genome that is actively transcribcd (up to 107copies pcr ecll) in latently infecled cells.19The oligonuclcolide was biotinylatcd using methods previously deseribcd.2OThe procedure used for the in situ hybridiz.ation studies has bcen describcd fully by us elscwhere. 10.20 Brieny. 10-¡lm seetions cut from paraffin blocks offormalin-fixed tissues were deparaffinizcd. dchydratcd. predigested with pronase, prehybridized. amI then hybridizcd ovemight at a coneentration 01'0.25 ¡lg/mL 01'probc. After washing, deteetion was accomplished by using avidin-alkaline phosphatasc eonjugate followcd by devclopment of the signal with McGadey's substr.¡te. A blue, black, or blue-blaek color in the nuclcus over background !eve!s was considered a positive reaction. This methodology detectcd EBV RNA from all eases ofknown EBV-positive acutc infeelious mononucleosis, nasopharyngca! Iymphocpithelioma, and post-transplantation Iymphoproliferative disorders. Lymphoid tissue from an EBV-seronegative patient and tissues infecte<! with herpes simplex virus 1, papilloma virus 16, and adenovirus showed no cross-rcactivity. Although a scnse strand oligonucleotide could nol be used as a negative control (bccausc of partial identity with adjacent antisense sequences), subSlitution ofthe probe with 10 other oligonuclcotictes of identical length and similar G-C content showed no staining. The staining pattern was abolishcd under any of the following conditions: preincubation with 9 ¡lg/IlL 01' boilcd ribonuclease A (Bóehringer Mannheim, Indianapolis, IN) at 3rC overnight using butTerconditions recommended by the manufacturer: omission of the labcled probc: or addition of a 50-fold excess of unlabeled probc to the hybridiz..ation solution. Any slide negative for EBV RNA was tested for preservation of total RNA using a poly d(T) probe as deseribcd elsewhere by US.21 lmmww}¡islochemical slUdies. Immunophenotypie studies wcrc pcrformed using several monoclonal anlibodies (MoAbs) that are reactive in routine paraffin-embcdded sections, using a previously 
RESULTS
The age and sex or the 32 patients and the histologic subtype of HD are given in Table l . The patients ranged in age rrom 2 to 75 years. with a median age of 9 years. Threequarters orthe paticnts werc less than 40 years old. The male to female ratio was 25:7. The most common histologic subtypcs were mixcd ccllularity (63%) and nodular sderosis (22%). There werc 4 cases of Iymphocyte depletion (12%) and ol1ly I case 01'dilruse Iymphocyte predominance (3%). There werc no cases of noduiar L&I-flymphocyte predominance HD.
The diagnosis of HD was cstablished histologieally using acccpted diagnostic critcria and was supported by immunohístochemical studies. The Reed-Stemberg cells in 29 01' the 32 cases (91%) showed mcmbrdne or ¡Jaranuclcar staining with CD 15. The Reed-Sternberg cells of 31 01'the 32 cases did not stain with CD45RB. The morphologic fc.1tures and immunologic staining profile was othcrwise typical of HD in thc sole CD45RB-positive case. CD20 stains were interpretable in 29 of the 32 cases. CD20 staining of Reed-Stcrnberg eells was observed in 2 cases of mixed cellularity (neither of which were the CD45RB-positive case describcd above); in these 2 cases. the Rced-Stcmberg cells also showcd CD 15 positivity and ¡hc morphologic fcaturcs were diagnostie of HD. CD43 stains were interprctable in 29 01' the 32 cases. No CD43 or CD3 staining of Reed-Sternberg cells and vanants was seen in any or the cases.
EBV RNA was identifico in all or virtually all ofthe ReedSternberg cells and varíants in 30 orthe 32 cases ofHD (94%) by in situ hybridization (Fig lA) . Rare scattered EBER-positive non-neoplastic Iymphocytes were also prcsent in these 30 cases. The 2 EBER-negativc cases were both of the Iymphocytc dcplction subtypc. In I 01' these cases. rare small Iymphoid cells werc EBER-positívc. whereas in the second case, no EBER staining was observed. despite adequate RNA shown by hybridization with a poi y d(T) probe. Twenty-five of the 30 EBER-positive cases (83%) were also positive for LMP1 (Fig lB) . In contrast to the EBER studies. the LMPl antibody labeled approximatcly half of the Reed-Sternberg cells in the positive cases. The 2 cases in which EBER was negative within Rced-Sternberg cells were both ncgative for LMPI. Double-Iabeling studíes. successful in all 32 cases. -. Doublc-Iabeling studics for CD20. CD43. and CD3 wcre performcd in a suhsct of JO cases. The studies found rare scattered EBER-positive small cclls colabcling with CD20 and much lcss oftcn with CD43 ano CD3. consistent with a rare population of EBV-infcctcd B and l' Iymphocytcs ( Fig  ID and E) . A statistical comparison of tlle associatioRbetween EBV and HD subtypes in the Peruvian versus Western cases of HD was pcrformed using the test with continuity correetion. The comparison wasperformed forthe two HD subtypei> for which adequate numbers of cases were avai1able:mixed ceUularityand nodular sclerosis.The casestl1atwere analyzed included the Pcruvian mixed cellularityand nodular sclerosis HD cases reported in Table land Western cases of mixed cel1ularity and nodular sclerosis HD tl1at were derived from OUrthree previous studies1o.24.2, that were performed using a probe andan in situ hybridization technique identical to that used in this study. The contingency table x2 analysis of the Western cases showed that distribution was the same in an tl1ree studies (mixedcellularity, P = .67, and nodular sclerosis, l' -.76) and, lhercfore, the da la was collapsed. A X2lest wilh conlinuily corrcetion performcd on the cases of Pcruvian nodular sclerosis I-lD versus Western nodular scJerosis HD showed that the difference in EBV distribution was statistically significant (P = .0021). The same analysis performed on the cases ofPeruvian mixed ceJlularity HD versus Western mixed cetlularity HD also showed a slatistically signifkant difference in EBV distribution (P = .0136).
A slatistical comparison 01' the association belween EBV and age in the Peruvian versus Western cases of HD was performed using the X2test. The comparison was performed for alll-ID subtypes for lhe adult age group (;;:;:21years old). The cases that were analyzed included the 12 Pcruvian HO cases reported in TabIe l and 28 cases of Wcstcrn HD that wcre derivcd from our previous study24 in which age of patieots was reported and that used a probe aod an in situ hybridization IcchniqL)e idenlical lo that usedin this study, A Xl test performed on lhe cases 01' Pcruvian HO versus , Western I-lD oflhe $ame age group showed that lhe difference in EBV distribution was slalistically significant (P = .0305).
DISCUSSION
Our cases ofPeruvian HD show interesting epidemiologic fcatures lha! distinguish this series from series reported in the United States and other developed countries, Firsl, the majority of our patients are children, with 63% less than 21 years old. The age distribution of our patient population is similar to that previously described in HD oecurring in Peru.1ó.2?In one study or20 cases ofHD oceurring in Peru,26 40% of the patients were 1ess than 19 years old, whereas in anothcr Peruvian study 01' 475 cases 01' HO,27 46% of the patients were children. HO in children has been rcported to be a relatively common disease in developing countries sueh as Brazil, Colombia, Lebanon, Mexieo, Costa Rica, and some parts of Aflíca.2s-n Seeond, there was an accentuation 01'the usual 3:2 mal e to female ratio, with a 25:7 malc to femalc raLÍofound in the current series. 'Ihis male predilection has also been reported in studies of HO occurring in Latín Ameriea, particularly in children.34 Third, in the eurrent series, mixed ecIlularity was the most eommon histoIogic subtype and Iymphocyte depletion was also rclatively freqlient, in contrast to the nodular sclerosing predominance and the rarity 01'Iymphocyte depletion in series of HD reported from the United States and other "Western" countries.35.36 Again, a predoll1inanee of mixed cellularity has been reported in some series from Third World countries, iocluding PeruY Lymphoid malignancies account for approximately 11% 01'al! malignancies seen at a majar cancer referral center in Peru; ofthese, approximatcly 521)'0 are Iymphomas and the rest are lcukemiasY 01' the lymphomas, liD accounts for approximatcIy 25%.
We found a statistically significant difference in the association between EBV and Peruvian and Western HD ofmixed cellularity and nodular sclerosing subtypes. Pallcsen et al12 and Vestlev et alJ? have previously documented a statistical!y sigi1ificant correlation bctwecn EBV and HD subtypes, with a high prevalence 01'EBV found in mixcd cellularity HD as opposed to other subtypes: howevcr, this assoeiation has nof been found in some other studies.II,J8 AIthough there was a 'Rfl/i.da )y(¿dí"" ck 'TI''!/(o high pcrcentagc of mixed cellularity cases in our study, a statistically signifícant higher numhef 01'cases 01' Peruvian HD was found tú express EBV than cases 01'Western HD, even when accounting for diflcrenccs in EBV cxprcssion in the different subtypes.
We also considcred the possibiJity lhat Ihe high rate 01' EBER~P~sitivity in the Peruvian liD cases was correlated with the low ageofthe patients, Such an assoeiation has been desci'ibed previously by JarreU et alJH in Western pediatric pati~nts, but this assoeiation has also not been confirmed by other investigators?? In our patient sample, 83% of patients over the age of21 years had EBER-pnsitive tumors. Our rate 01'EBV-positivity in Peruvian adullllD was statistically significantly greater when compared with previously reported cases ofWestcrn liO in palients over 21 years.24 We cannot exclude the possibility that the high rale of EBV-positivity may be partially cxplaincd by thc agc of our patient population; however, our findingsdocul11ent an increased prev-' alenee of EBV-posilivity in Péruvian 110 in all age groups.
Thirty ofthe 32 cases (940/';)of Perllvian HD were found to cantain EBV RNA. This percentage is similar to t!1Crate ' 01'EBV-positivity in endemic B,urkitt's Iymphoma, HO\vever, it is in sharp contrast to the much lowcr percentage ofEBVassociated cases of I-lD occurring in "Western" patients, For example, using an identical in situ mcthodology, we found onl)-10 of 22 cases (45%) 01'classical HD occurring in immunocompctent North Americans to express EBV RNA within Recd-Sternbcrg eclls and variants.1o It is not surprising that the paraflln immunohistochetl1lcal studies for LMP I were slightly less sensitive than the EBER in situ hyb¡idization studics for the detection of EBV; a similar obscrvation has been previollsly rcported.12.13Ocnaturation oftheLMPI al1-tigen during formalin lixatíon may account for some EBERpositive cases not slaining with LMPI.I2 80th ofthe EBVnegalive cases were 01'the Iymphocyte depletion subtype, a histOlogie sllbtype nOloriaus for confllsion with non-Hodgkin's lymphoma39; lherefore, it is possible that these two cases may not actually represent l-ID, but rather, pleomorphie nOI1-Hodgkin's Iymphoma mimicking HD. Howevcr, both cases showed no staining with EMA and, thus, were eonsidered unlikcly to be anaplastic large-celllymphomas.4o Additionally, the morphologic fealures were fel! lO be more compatible with HD than non-Hodgkin's Iymphoma, and the phenotypes . (COI5+, CD45RB-, C020-, CD43' and CDIS-, CD45RB", CD20-, C04r) were considered either to favor HO (former phcnotype) or be equivocal (laucr phcnotype), We also observed EBV RNA within smaller cells that were identified by dOllble-labcling studies to be predominantly B cells 01',less frequently, T eells, Although we cannot excludc the possibility that these cells, or a subset 01'these cells, represcnt a population rclated to the neoplastic population (such as a precursor population), we think that it is much more probable that these cells represent an expanded pool of EBVpositive non-neoplastic B cells beca use 01' the immunosuppression present in these individuals. We have noted similar EBV-positive small cells in bcnign Iyrnph nade biopsies.IO,41Interesling,ly, rare CD43-positive or CD3-positive cells, presumably T Iymphocytes, wer, also found to be EBV positive in addition to the expccted CD20-positive B-lineagc 
